Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making

Article

Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).

Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).

DCIS, often considered stage 0 breast cancer, is one step before invasive breast cancer and can be treated by radiation, drugs or mastectomy to minimize chance of recurrence. However, Van Zee emphasizes that not many women want to undergo these treatments at such an early stage.

The nomogram is a tool that patients and their health care providers can use to estimate risk of recurrence, so that appropriate treatment decisions can be made.

Related Videos
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.